{"name": "Gallus BioPharmaceuticals",
 "permalink": "gallus-biopharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/gallus-biopharmaceuticals",
 "homepage_url": "http://www.gallusbiopharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@gallusbiopharma.com",
 "phone_number": "(314) 426-5000",
 "description": "",
 "created_at": "Sat May 21 01:37:52 UTC 2011",
 "updated_at": "Sat May 21 01:37:50 UTC 2011",
 "overview": "\u003Cp\u003EGallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally. It also provides process development, analytical development, process validation, cell banking, stability testing, QA/QC, and regulatory support solutions. The company was founded in 2010 and is based in Wellesley, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       16],
      "assets/images/resized/0013/5657/135657v1-max-150x150.png"],
     [[250,
       28],
      "assets/images/resized/0013/5657/135657v1-max-250x250.png"],
     [[450,
       50],
      "assets/images/resized/0013/5657/135657v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Mark",
      "last_name": "Bamforth",
      "permalink": "mark-bamforth",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Steven",
      "last_name": "Kasok",
      "permalink": "steven-kasok",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/05/gallus-biopharmaceuticals-receives-majority-investment-ridgemont-equity-partners.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Gallus BioPharmaceuticals Receives Majority Investment from Ridgemont Equity Partners",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ridgemont Equity Partners",
         "permalink": "ridgemont-equity-partners",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0019/4137/194137v1-max-150x150.jpg"],
             [[249,
               74],
              "assets/images/resized/0019/4137/194137v1-max-250x250.jpg"],
             [[249,
               74],
              "assets/images/resized/0019/4137/194137v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4766 LaGuardia Drive",
    "address2": "",
    "zip_code": "63134",
    "city": "St. Louis",
    "state_code": "MO",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}